FedQuery

Ppd Development Lp

UEI ZANENSW6C665 · NC · subsidiary of Ppd Development Lp · SAM.gov record ↗

$32.5M
FY2025 obligations
34
Contract awards
Oct 31, 2011
First action
Jun 28, 2026
Latest action

Monthly obligations

Oct 24
Dec 24
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Sep 25
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Jun 26

Contracts ending within 18 months (recompete watch)

  • REGULATORY MANAGEMENT CENTER (RMC)

    Ends
    Oct 30, 2026
    Started
    Oct 31, 2021
    Agency
    National Institutes Of Health
    NAICS
    541714
  • DAIDS MONITORING FOR 1 PHASE III STUDY: A5300B/I2003B (PHOENIX)

    Ends
    Dec 13, 2026
    Started
    Dec 14, 2025
    Agency
    National Institutes Of Health
    NAICS
    541714
  • TASK AREA A: ADMINISTRATION AND OVERALL CLINICAL OPERATIONS SUPPORT AND CONCEPT DEVELOPMENT

    Ends
    Jan 12, 2027
    Started
    Jan 13, 2022
    Agency
    National Institutes Of Health
    NAICS
    541715
  • NIAID CLINICAL SITE MONITORING (NCSM)

    Ends
    Jan 30, 2027
    Started
    Jan 31, 2024
    Agency
    National Institutes Of Health
    NAICS
    541714
  • TASK ORDER AWARD- PHASE I CLINICAL TRIALS FOR THE DEVELOPMENT OF NEUROTHERAPEUTICS- DTI-117 IN HEALTHY VOLUNTEERS/SAD AND MAD CT

    Ends
    Apr 27, 2027
    Started
    Jun 28, 2026
    Agency
    National Institutes Of Health
    NAICS
    541712
  • NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) CLINICAL SITE MONITORING CENTER (CSMC)

    Ends
    Jun 28, 2027
    Started
    Jun 29, 2022
    Agency
    National Institutes Of Health
    NAICS
    541715
  • FDABAA-24-00123, REF # FY24C1EP6, CARDIOVASCULAR-KIDNEY-METABOLIC (CKM) SYNDROME PATIENT-REPORTED OUTCOME (PRO) BURDEN MEASURE

    Ends
    Jul 14, 2027
    Started
    Sep 10, 2024
    Agency
    Food And Drug Administration
    NAICS
    541714
  • MOD P00001 - TO CHANGE CONTRACT TYPE FOR BAA-FY24C3CP5-UNDERSTANDING HETEROGENEITY IN PREFERENCES FOR CLINICAL TRIAL PARTICIPATION IN DIVERSE PATIENT POPULATIONS.

    Ends
    Nov 21, 2027
    Started
    Sep 23, 2024
    Agency
    Food And Drug Administration
    NAICS
    541720

Largest awards

  • NIAID CLINICAL SITE MONITORING (NCSM)

    Ends
    Jan 30, 2027
    Started
    Jan 31, 2024
    Agency
    National Institutes Of Health
    NAICS
    541714
  • NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) CLINICAL SITE MONITORING CENTER (CSMC)

    Ends
    Jun 28, 2027
    Started
    Jun 29, 2022
    Agency
    National Institutes Of Health
    NAICS
    541715
  • EOI::RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING::EOI BILATERAL

    Ends
    Aug 13, 2026
    Started
    Aug 14, 2024
    Agency
    National Institutes Of Health
    NAICS
    541714
  • REGULATORY MANAGEMENT CENTER (RMC)

    Ends
    Oct 30, 2026
    Started
    Oct 31, 2021
    Agency
    National Institutes Of Health
    NAICS
    541714
  • DAIDS MONITORING FOR 1 PHASE III STUDY: A5300B/I2003B (PHOENIX)

    Ends
    Dec 13, 2026
    Started
    Dec 14, 2025
    Agency
    National Institutes Of Health
    NAICS
    541714
  • DAIDS ONSITE MONITORING FOR 1 PHASE III STUDY: A5300B/PHOENIX

    Ends
    Dec 13, 2025
    Started
    Apr 14, 2019
    Agency
    National Institutes Of Health
    NAICS
    541711
  • MOD P00001 - TO CHANGE CONTRACT TYPE FOR BAA-FY24C3CP5-UNDERSTANDING HETEROGENEITY IN PREFERENCES FOR CLINICAL TRIAL PARTICIPATION IN DIVERSE PATIENT POPULATIONS.

    Ends
    Nov 21, 2027
    Started
    Sep 23, 2024
    Agency
    Food And Drug Administration
    NAICS
    541720
  • TASK AREA A: ADMINISTRATION AND OVERALL CLINICAL OPERATIONS SUPPORT AND CONCEPT DEVELOPMENT

    Ends
    Jan 12, 2027
    Started
    Jan 13, 2022
    Agency
    National Institutes Of Health
    NAICS
    541715
  • RESEARCH AND DEVELOPMENT FOR CLINICAL STUDIES IN THE BLUEPRINT MEDTECH. CLINICAL STUDY PROTOCOL DEVELOPMENT. TASK ORDER 02. 06/17/2024 - 06/16/2029.

    Ends
    Jun 15, 2029
    Started
    Jun 16, 2024
    Agency
    National Institutes Of Health
    NAICS
    541715
  • CONTRACT RESEARCH ORGANIZATION (CRO) SUPPORT FOR BLUEPRINT MEDTECH (BPMT) REGULATORY AFFAIRS SUPPORT AND RELATED SERVICES. REGULATORY PATHWAY AND MARKET ACCESS SUPPORT. TASK ORDER 03. 04/09/2024 - 04/08/2029.

    Ends
    Apr 7, 2029
    Started
    Apr 8, 2024
    Agency
    National Institutes Of Health
    NAICS
    541715
  • TASK ORDER AWARD- PHASE I CLINICAL TRIALS FOR THE DEVELOPMENT OF NEUROTHERAPEUTICS- DTI-117 IN HEALTHY VOLUNTEERS/SAD AND MAD CT

    Ends
    Apr 27, 2027
    Started
    Jun 28, 2026
    Agency
    National Institutes Of Health
    NAICS
    541712
  • TASK ORDER75N95025F00001 TO4 BLUEPRINT MEDTECH PREPARATION OF PRE-SUBMISSION SUPPORT FOR PILOT PARTICIPANT.

    Ends
    Dec 18, 2025
    Started
    Dec 19, 2024
    Agency
    National Institutes Of Health
    NAICS
    541715
  • ONE ACQUISITION SOLUTION FOR INTEGRATED SERVICES PLUS (OASIS+) UNRESTRICTED MULTIPLE AGENCY CONTRACT (MAC)

    Ends
    Started
    Dec 16, 2024
    Agency
    Federal Acquisition Service
    NAICS
    541690
  • OMNIBUS IV MILITARY MEDICAL RESEARCH AND DEVELOPMENT

    Ends
    Started
    Jun 19, 2022
    Agency
    Defense Health Agency
    NAICS
    541714
  • EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI TERMINATION FOR CONVENIENCE. CLINICAL RESEARCH AND STUDY MONITORING SUPPORT FOR NIMH STUDIES

    Ends
    May 14, 2025
    Started
    Sep 27, 2022
    Agency
    National Institutes Of Health
    NAICS
    541990
  • EPCTU - TO IMPLEMENT PHASE 0 TO PHASE II CLINICAL TRIALS, INCLUDING PROOF-OF-CONCEPT STUDIES IN HEALTHY AND DISEASED HUMAN POPULATIONS, DOMESTICALLY AND INTERNATIONALLY, AIDED BY BIOANALYSIS WHEN NECESSARY. PHASE III STUDIES MAY BE CONDUCTED OCCASI

    Ends
    Jan 30, 2026
    Started
    Jun 28, 2023
    Agency
    National Institutes Of Health
    NAICS
    541715
  • SAHN SINGLE ASCENDING DOSE (SAD) PHASE I STUDY (4ET1103)

    Ends
    Jun 29, 2026
    Started
    Jul 7, 2016
    Agency
    National Institutes Of Health
    NAICS
    541712
  • FDABAA-24-00123, REF # FY24C1EP6, CARDIOVASCULAR-KIDNEY-METABOLIC (CKM) SYNDROME PATIENT-REPORTED OUTCOME (PRO) BURDEN MEASURE

    Ends
    Jul 14, 2027
    Started
    Sep 10, 2024
    Agency
    Food And Drug Administration
    NAICS
    541714
  • THE PURPOSE OF THIS MODIFICATION IS TO: 1. UPDATE SECTION G.1 OF THE CONTRACT TO CHANGE THE CONTRACTING OFFICER TO JILL JOHNSON. TALL OTHER TERMS AND CONDITIONS REMAIN THE SAME.

    Ends
    Sep 27, 2029
    Started
    Sep 28, 2023
    Agency
    Office Of Assistant Secretary For Preparedness And Response
    NAICS
    541715
  • BARDA WILL IMPLEMENT A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER PHASE 2 TRIAL IN THE US TO EVALUATE THE SAFETY AND EFFICACY OF NOVEL HOST-DIRECTED THERAPEUTIC CANDIDATES IN HOSPITALIZED ADULTS WITH ARDS.

    Ends
    Sep 29, 2030
    Started
    Dec 14, 2023
    Agency
    Office Of Assistant Secretary For Preparedness And Response
    NAICS
    541714
  • COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMS

    Ends
    Started
    Aug 31, 2021
    Agency
    National Institutes Of Health
    NAICS
    541714
  • EARLY PHASE CLINICAL TRIAL UNITS (EPCTU)

    Ends
    Started
    Jan 13, 2022
    Agency
    National Institutes Of Health
    NAICS
    541715
  • CONTRACT RESEARCH ORGANIZATION (CRO) SUPPORT FOR BLUEPRINT MEDTECH (BPMT) REGULATORY AFFAIRS SUPPORT AND RELATED SERVICES. ORDERING PERIOD: 9/22/2022 - 9/21/2027. N02DA-22-1235.

    Ends
    Started
    Sep 21, 2022
    Agency
    National Institutes Of Health
    NAICS
    541715
  • RESEARCH AND DEVELOPMENT FOR CLINICAL STUDIES IN THE BLUEPRINT MEDTECH. ORDERING PERIOD: 09/01/2023 - 8/31/2028. (BPMT) INITIATIVE.

    Ends
    Started
    Aug 31, 2023
    Agency
    National Institutes Of Health
    NAICS
    541715
  • REGULATORY MANAGEMENT CENTER

    Ends
    Oct 30, 2021
    Started
    Oct 31, 2011
    Agency
    National Institutes Of Health
    NAICS
    541711